Directory

>

James Kang

avatar

James Kang

Vice President, Head of Intellectual Property | Obsidian Therapeutics

Cambridge, Massachusetts, United States

View contact details (it's free)

James Kang

Summary

James Kang is a seasoned professional with extensive experience in intellectual property within the biopharmaceutical sector. Currently serving as the Vice President and Head of Intellectual Property at Obsidian Therapeutics, he has a robust background in patent law and biochemistry. His career spans roles in leading pharmaceutical companies, where he has honed his expertise in drug development and assay development. James holds a Juris Doctor degree from Rutgers University and a Master's degree in Biochemistry from the University of Pennsylvania. He is recognized for his ability to bridge the gap between legal and scientific realms, making him a valuable asset in any organization focused on innovation. Outside of his professional life, he is passionate about advancing the field of biotechnology through sustainable practices and emerging technologies.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

James Kang

Work Experience

company logo

Vice President, Head of Intellectual Property at

Obsidian Therapeutics

April 2022 - Present

company logo

Senior Counsel, IP at

Takeda Pharmaceuticals America, Inc.

May 2020 - April 2022

company logo

Patent Counsel at

GSK

May 2016 - May 2020

company logo

Associate, Intellectual Property at

Gibbons P.C.

January 2013 - January 2015

company logo

Associate, Intellectual Property at

Chiesa Shahinian & Giantomasi PC

January 2015 - January 2015

company logo

Patent Liaison at

Regeneron

January 2008 - January 2013

company logo

Research Associate IV at

Regeneron

January 2007 - January 2008

company logo

Associate Scientist at

Centocor

January 2005 - January 2007

Logos provided by Logo.dev

James Kang

Education

Rutgers University School of Law - Newark, Doctor Of Law (J.D.)

January 2008 - January 2012

University of Pennsylvania School of Medicine, Master Of Science (M.S.)

January 2001 - January 2004

Brandeis University, Bachelor Of Arts (B.A.)

January 1994 - January 1998

Frequently Asked Questions about James Kang

What is James Kang email address?

James Kang's primary email address is *****@obsidiantx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does James Kang work for?

James Kang is a Vice President, Head of Intellectual Property at Obsidian Therapeutics, a company specializing in Commercial physical research.

Where James Kang graduated from?

James Kang holds a degree in from Rutgers University School of Law - Newark.

How can I directly contact James Kang?

To contact James Kang directly, you can use the email address *****@obsidiantx.com. Complete contact information is available upon registration with Muraena.

Who is James Kang?

James Kang is a seasoned professional with extensive experience in intellectual property within the biopharmaceutical sector. Currently serving as the Vice President and Head of Intellectual Property at Obsidian Therapeutics, he has a robust background in patent law and biochemistry. His career spans roles in leading pharmaceutical companies, where he has honed his expertise in drug development and assay development. James holds a Juris Doctor degree from Rutgers University and a Master's degree in Biochemistry from the University of Pennsylvania. He is recognized for his ability to bridge the gap between legal and scientific realms, making him a valuable asset in any organization focused on innovation. Outside of his professional life, he is passionate about advancing the field of biotechnology through sustainable practices and emerging technologies.

James`s contact details

mail

*****@obsidiantx.com

*****@tpna.com

******@massbbo.org

Colleagues

avatar
Nicole Hsu

Vice President Regulatory Affairs

avatar
Gwen Wilmes

Vice President, Analytical Development

avatar
Michelle Ols

Vice President, Head of Cell Therapy

avatar
Nic Betts

Vice President of IT and Facilities

avatar
Giri Ramsingh

Vice President Clinical Sciences

avatar
Chirag Khatiwala

Vice President - Process Development and Manufacturing

avatar
Jennifer Peterson

Chief People Officer

avatar
Madan Jagasia

Chief Executive Officer

avatar
Prakash Prabhakar

Vice President, Clinical Operations & Translational Early Clinical Development

View Contact details (it's free)
Request Profile Removal